Researchers Develop First-in-Class Inhibitors Against Key Leukemia Protein

Approach opens a new avenue to study the biology of acute leukemia and for the development of new drugs.

5:00 AM

Author | Ian Demsky

protein in pink and blue an light grey with lab note badge spelled out on bottom right in yellow background and navy font
An X-ray crystallography image showing an ASH1L inhibitor developed at U-M in complex with the protein.

The protein made by the ASH1L gene plays a key role in the development of acute leukemia, along with other diseases. The ASH1L protein, however, has been challenging to target therapeutically.

Now a team of researchers led by Jolanta Grembecka, Ph.D., and Tomasz Cierpicki, Ph.D., from the University of Michigan has developed first-in-class small molecules to inhibit ASH1L's SET domain — preventing critical molecular interactions in the development and progression of leukemia.

The team's findings, which used fragment-based screening, followed by medicinal chemistry and a structure-based design, appear in Nature Communications.

In mouse models of mixed lineage leukemia, the lead compound, known as AS-99, successfully reduced leukemia progression.

"This work points to a new, exiting avenue to develop new therapeutic agents against acute leukemia, as well as providing a new approach to further study the biological functions of ASH1L and its role in the development of the disease," says Grembecka, associate professor of pathology at Michigan Medicine and co-director of the developmental therapeutics program at the U-M Rogel Cancer Center.  

The study was a close collaboration between her lab and the lab of co-senior author Cierpicki, an associate professor of biophysics and pathology.

Paper citied: "Discovery of first-in-class inhibitors of ASH1L histone methyltransferase with anti-leukemic activity," Nature Communications. DOI:10.1038/s41467-021-23152-6


More Articles About: Lab Notes Leukemia Cancer Research Basic Science and Laboratory Research Cancer: Cancer Types
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories lime green structure with purple in left middle and lab note badge in navy and yellow in bottom right
Health Lab
Researchers develop first inhibitors against key epigenetic complex involved in cancer
Activity of the polycomb repressive complex 1 is essential for the development and maintenance of leukemic cells; disrupting it presents a new potential therapeutic approach.
doctors in surgery room over surgery table with cooler open with labels on it
Health Lab
Why donor hearts fail in cold storage — and how to prevent it
Researchers have discovered a new molecular process that occurs when donor hearts are preserved in cold storage which contributes to failure after transplant, a study in both humans and animals shows. Fortunately, therapy that is typically prescribed for high blood pressure can target this process to reduce cold preservation associated with cardiac injury. This discovery has potential to improve the consistent function of donor hearts and extend the distance they can be safely transported in cold storage.
chess pieces yellow background one red piece on right and yellow on left weighing the balance beam down
Health Lab
Interplay between key proteins could serve as a target for cancer treatment
University of Michigan researchers have identified that the balance between two proteins—STAT3 and STAT5—is important for making tumors vulnerable to immune checkpoint therapy, and targeting STAT3 degradation is a potential novel cancer immunotherapy strategy.
hands on a robotic handle for surgery
Health Lab
Bile duct injury rates higher from robotic assisted cholecystectomy
Robotic-assisted cholecystectomies produce a higher risk of bile duct injuries than laparoscopic cholecystectomies for patients at all types of risks.
drawing on orange background of colorful pills floating with body parts in them in pain
Health Lab
Cerebral palsy medications given to adults may not match needs
Prescribing medications that treat the most obvious parts of adult cerebral palsy pain and symptoms without examining for the underlying cause is a common experience for adults with cerebral palsy. This means that proper treatment is being overlooked and these medications can cause further complications later in life.
nurse in maroon at patient bedside
Health Lab
Studying interventions to help type 2 diabetes patients avoid hospitalizations
Research from University of Michigan will be looking at the way social determinants of health can have an impact on the health of people living with type 2 diabetes.